Optional Sub-study to Intraoperative Imaging With ICG Registry

Completed

Conditions studied: Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer, Cancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma Cancer, Cancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer

In brief

The primary goal of this optional sub-study is to record what tissues fluoresce in the operating room, and then to identify if these lesions are cancer when the histopathology is performed.

Key facts

Study ID

NCT02651246

Run by

Abramson Cancer Center at Penn Medicine

People needed

291

Starts

2015-12-01

Expected to finish

2020-02-01

Last updated by the study team

2021-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients >= 18 years of age
• Patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and are at risk for recurrence.
• Good operative candidate as determined by the treating physician and/or multidisciplinary team
• Subject capable of giving informed consent and participating in the process of consent.

You may not qualify if…

• Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
• Vulnerable patient populations

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.